Hostname: page-component-848d4c4894-pjpqr Total loading time: 0 Render date: 2024-06-17T07:57:41.137Z Has data issue: false hasContentIssue false
  • English
  • Français

Representations of long-acting antipsychotics in patients at the Arrazi hospital in Salé Morocco

Published online by Cambridge University Press:  19 July 2023

H. Chebli ,
A. Tounsi ,
H. Berrada ,
F. Laboudi  and
A. Ouanass
H. Chebli*
Affiliation:
1University Psychiatric Hospital Arrazi in Sale, Sale
A. Tounsi
Affiliation:
1University Psychiatric Hospital Arrazi in Sale, Sale
H. Berrada
Affiliation:
1University Psychiatric Hospital Arrazi in Sale, Sale
F. Laboudi
Affiliation:
2University Psychiatric Hospital Arrazi in Sale, Casablanca, Morocco
A. Ouanass
Affiliation:
2University Psychiatric Hospital Arrazi in Sale, Casablanca, Morocco
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Since the appearance of long-acting antipsychotics (LAPAs) and given the high frequency of non-adherence to treatment in psychotic disorders, LAPAs have recognized a resurgence of interest in the psychiatric literature. These long-acting drugs may pose ethical issues (e.g. limitation of freedom).

Objectives

The present study aims to determine the representations of long-acting antipsychotics in patients followed at Arrazi Hospital in Salé.

Methods

Descriptive study carried out with patients hospitalized at the Arrazi hospital in Salé and those followed in consultation who are on APAP or who have already used it. The collection of information is done using an exploitation sheet

Results

APAPs have been used for less than 5 years by 53.8% of patients84.6% of participants do not use APAP bychoice, in 79.2% of cases it was the doctor’s decision and in 20.8% of cases it was the family’s choiceMonotherapytreatment was the most cited benefit by our patients (76.9%)The route of administration of APAP by intramuscular injection is the problem encountered in 57.7% of our patients, while11.5% of patients find no inconvenience for the use of these psychotropics.

Conclusions

Negative beliefs associated with the treatment contribute to a very large part to the lack of compliance, onthe contrary, long-acting antipsychotics may be better accepted by patients when taking into account the patients’ beliefsand preferences in the development of the treatment. therapeutic project

Disclosure of Interest

None Declared

Type
Abstract
Information
European Psychiatry , Volume 66 , Special Issue S1: Abstracts of the 31st European Congress of Psychiatry , March 2023 , pp. S265
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.